Market revenue in 2023 | USD 591.1 million |
Market revenue in 2030 | USD 965.7 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Molecular diagnostics |
Fastest growing segment | Immunoassays |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoassays, Hematology and Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy |
Key market players worldwide | Quest Diagnostics Inc, 23andMe Holding Co Class A, Abbott Laboratories, Guardant Health Inc, NeoGenomics, Siemens Healthineers AG ADR, Qiagen NV, Illumina Inc, Roche Holding AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory developed tests market will help companies and investors design strategic landscapes.
Molecular diagnostics was the largest segment with a revenue share of 26.12% in 2023. Horizon Databook has segmented the Italy laboratory developed tests market based on immunoassays, hematology and coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy covering the revenue growth of each sub-segment from 2018 to 2030.
The LDTs market in Italy is growing and characterized by several innovative companies focused on developing new & improved diagnostic tools to meet the needs of healthcare providers & patients. Some of the companies in the country’s market include DiaSorin, Grifols, Bioiberica, CNR Institute of Clinical Physiology, and San Raffaele Hospital.
In January 2021, DiaSorin announced the launch of CEmarked LIAISON SARS-CoV-2 TrimericS IgG assay, which determines IgG antibodies against SARS-COV2. In addition, in May 2020, Grifols announced completing the development of a molecular test that could detect SARS-CoV-2 virus.
The LDT market in the country is growing and expected to grow in the coming years as companies are continuously working to improve the quality & availability of these tests.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy laboratory developed tests market , including forecasts for subscribers. This country databook contains high-level insights into Italy laboratory developed tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account